Differences
This shows you the differences between two versions of the page.
| Both sides previous revisionPrevious revision | Both sides next revision |
pharmaceutical_companies:regeneron [2023/05/11 20:55]
liam | pharmaceutical_companies:regeneron [2023/05/11 20:55] (current)
liam |
|---|
| {{ :pharmaceutical_companies:regeneron_pharmaceuticals_logo_.png?200|}} | {{ :pharmaceutical_companies:regeneron_pharmaceuticals_logo_.png?200|}} |
| |
| **Regeneron Pharmaceuticals, Inc.** is an American biotechnology company based in [[united_states:new_york:Mount Pleasant]], [[united_states:New York]]. | **Regeneron Pharmaceuticals, Inc.** is an American biotechnology company based in [[:united_states:new_york:Mount Pleasant]], [[:united_states:New York]]. |
| | |
| | ===== History ===== |
| | |
| | On August 19, 2020, Regeron announced a collaboration with [[Roche]] "on developing and manufacturing [[:REGN-COV2]]", Regeneron's experimental [[:monoclonal antibody]] cocktail for use against [[:COVID-19]].((Bowie, A. (2020, August 19). //Regenereon and Roche collaborate to significantly increase global supply of REGN-CoV2 investigational antibody cocktail for COVID-19.// Regeneron Pharmaceuticals. https://newsroom.regeneron.com/news-releases/news-release-details/regeneron-and-roche-collaborate-significantly-increase-global)) |
| |
| ===== External links ===== | ===== External links ===== |
| |
| * [[https://en.wikipedia.org/wiki/Regeneron_Pharmaceuticals|Wikipedia]] | * [[https://en.wikipedia.org/wiki/Regeneron_Pharmaceuticals|Wikipedia]] |
